Converging evidence suggests the possible role of oxytocin in several aspects of PTSD pathophysiology, as exogenous oxytocin therapy has been shown to modulate fear responses and anxiety symptoms arising from aversive experiences [47]. This evidence concerns the gene OXT and post-traumatic stress disorder.